Moelis Analyst Ratings
Moelis Analyst Ratings
Moelis 分析師評級
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/03/2023 | -31.02% | UBS | $29 → $30 | Maintains | Sell |
| 07/27/2023 | 28.77% | JP Morgan | $45 → $56 | Maintains | Neutral |
| 07/12/2023 | -10.32% | Morgan Stanley | $29 → $39 | Maintains | Underweight |
| 07/12/2023 | -8.02% | Goldman Sachs | $35 → $40 | Maintains | Sell |
| 06/27/2023 | -33.32% | Morgan Stanley | $29 → $29 | Reiterates | Underweight → Underweight |
| 04/27/2023 | -14.92% | Keefe, Bruyette & Woods | $40 → $37 | Maintains | Underperform |
| 04/12/2023 | -33.32% | Morgan Stanley | $30 → $29 | Maintains | Underweight |
| 03/24/2023 | -17.22% | Goldman Sachs | $40 → $36 | Maintains | Sell |
| 02/09/2023 | -3.43% | Goldman Sachs | $38 → $42 | Maintains | Sell |
| 01/11/2023 | -14.92% | Goldman Sachs | $40 → $37 | Downgrades | Neutral → Sell |
| 01/09/2023 | -31.02% | UBS | $32 → $30 | Maintains | Sell |
| 11/03/2022 | -8.02% | JP Morgan | $42 → $40 | Maintains | Neutral |
| 11/03/2022 | -14.92% | Keefe, Bruyette & Woods | $40 → $37 | Downgrades | Market Perform → Underperform |
| 10/07/2022 | -12.62% | Goldman Sachs | $43 → $38 | Maintains | Neutral |
| 09/23/2022 | -19.52% | UBS | $43 → $35 | Downgrades | Neutral → Sell |
| 07/28/2022 | -1.13% | UBS | $40 → $43 | Maintains | Neutral |
| 07/18/2022 | -17.22% | Morgan Stanley | $53 → $36 | Downgrades | Equal-Weight → Underweight |
| 07/11/2022 | -3.43% | Wolfe Research | → $42 | Downgrades | Peer Perform → Underperform |
| 07/08/2022 | 3.47% | Piper Sandler | $50 → $45 | Maintains | Neutral |
| 07/06/2022 | -8.02% | UBS | $54 → $40 | Downgrades | Buy → Neutral |
| 04/28/2022 | 14.97% | Piper Sandler | → $50 | Downgrades | Overweight → Neutral |
| 04/12/2022 | 3.47% | Goldman Sachs | $50 → $45 | Maintains | Neutral |
| 04/07/2022 | 19.57% | Piper Sandler | $61 → $52 | Maintains | Overweight |
| 04/06/2022 | 31.06% | Keefe, Bruyette & Woods | → $57 | Downgrades | Outperform → Market Perform |
| 03/09/2022 | 40.26% | Piper Sandler | $70 → $61 | Maintains | Overweight |
| 03/08/2022 | 21.87% | Morgan Stanley | $65 → $53 | Maintains | Equal-Weight |
| 02/11/2022 | 60.96% | Piper Sandler | $78 → $70 | Upgrades | Neutral → Overweight |
| 02/10/2022 | 49.46% | Morgan Stanley | $68 → $65 | Maintains | Equal-Weight |
| 01/06/2022 | 49.46% | Goldman Sachs | $68 → $65 | Upgrades | Sell → Neutral |
| 01/04/2022 | 67.85% | UBS | $85 → $73 | Maintains | Buy |
| 12/17/2021 | 77.05% | Keefe, Bruyette & Woods | → $77 | Upgrades | Market Perform → Outperform |
| 12/08/2021 | 56.36% | Morgan Stanley | $75 → $68 | Maintains | Equal-Weight |
| 10/11/2021 | 56.36% | Morgan Stanley | $63 → $68 | Maintains | Equal-Weight |
| 07/22/2021 | 44.86% | Morgan Stanley | $60 → $63 | Maintains | Equal-Weight |
| 06/17/2021 | 44.86% | Wolfe Research | → $63 | Upgrades | Underperform → Peer Perform |
| 04/09/2021 | — | JMP Securities | Downgrades | Market Outperform → Market Perform | |
| 04/07/2021 | 37.96% | Morgan Stanley | $57 → $60 | Maintains | Equal-Weight |
| 02/11/2021 | 31.06% | Morgan Stanley | $55 → $57 | Maintains | Equal-Weight |
| 01/11/2021 | 26.47% | Morgan Stanley | $52 → $55 | Maintains | Equal-Weight |
| 01/07/2021 | 14.97% | JP Morgan | $34 → $50 | Upgrades | Underweight → Neutral |
| 01/05/2021 | 28.77% | UBS | $40 → $56 | Upgrades | Neutral → Buy |
| 12/16/2020 | — | Seaport Global | Initiates Coverage On | → Neutral | |
| 12/14/2020 | 19.57% | Morgan Stanley | $41 → $52 | Maintains | Equal-Weight |
| 10/27/2020 | -5.73% | Piper Sandler | $37 → $41 | Maintains | Neutral |
| 10/12/2020 | -5.73% | Morgan Stanley | $29 → $41 | Maintains | Equal-Weight |
| 10/09/2020 | -3.43% | JMP Securities | $37 → $42 | Maintains | Market Outperform |
| 10/09/2020 | — | Keefe, Bruyette & Woods | Downgrades | Outperform → Market Perform | |
| 08/05/2020 | -44.81% | Goldman Sachs | $27 → $24 | Downgrades | Neutral → Sell |
| 07/30/2020 | -28.72% | Piper Sandler | $32 → $31 | Maintains | Neutral |
| 07/30/2020 | -33.32% | Morgan Stanley | $31 → $29 | Maintains | Equal-Weight |
| 07/13/2020 | -37.92% | Goldman Sachs | $34 → $27 | Downgrades | Buy → Neutral |
| 07/10/2020 | -26.42% | Piper Sandler | $40 → $32 | Downgrades | Overweight → Neutral |
| 07/07/2020 | -40.22% | JP Morgan | $20 → $26 | Downgrades | Neutral → Underweight |
| 04/09/2020 | -28.72% | Morgan Stanley | $37 → $31 | Maintains | Equal-Weight |
| 04/09/2020 | -10.32% | JMP Securities | $45 → $39 | Maintains | Market Outperform |
| 03/25/2020 | -35.62% | UBS | $33 → $28 | Maintains | Neutral |
| 02/06/2020 | 12.67% | JP Morgan | $44 → $49 | Maintains | Overweight |
| 02/06/2020 | -5.73% | Buckingham Research | $39 → $41 | Maintains | Buy |
| 12/11/2019 | -19.52% | Morgan Stanley | $37 → $35 | Maintains | Equal-Weight |
| 11/20/2019 | -14.92% | Morgan Stanley | $39 → $37 | Maintains | Equal-Weight |
| 10/09/2019 | -10.32% | Buckingham Research | $44 → $39 | Maintains | Buy |
| 10/08/2019 | -10.32% | Morgan Stanley | $41 → $39 | Maintains | Equal-Weight |
| 07/31/2019 | -10.32% | Keefe, Bruyette & Woods | $42 → $39 | Downgrades | Outperform → Market Perform |
| 07/11/2019 | 1.17% | Buckingham Research | $53 → $44 | Maintains | Buy |
| 07/08/2019 | -5.73% | Morgan Stanley | $45 → $41 | Maintains | Equal-Weight |
| 04/11/2019 | — | B of A Securities | Downgrades | Buy → Underperform | |
| 04/08/2019 | 14.97% | JMP Securities | $56 → $50 | Maintains | Market Outperform |
| 01/08/2019 | 5.77% | Morgan Stanley | $59 → $46 | Maintains | Equal-Weight |
| 11/06/2018 | 21.87% | Goldman Sachs | → $53 | Initiates Coverage On | → Buy |
| 10/23/2018 | 24.17% | UBS | $59 → $54 | Maintains | Neutral |
| 10/08/2018 | 35.66% | UBS | $62 → $59 | Maintains | Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 10/03/2023 | -31.02% | 瑞銀集團 | $29→$30 | 維護 | 賣 |
| 07/27/2023 | 28.77% | 摩根大通 | $45→$56 | 維護 | 中性 |
| 07/12/2023 | -10.32% | 摩根士丹利 | $29→$39 | 維護 | 體重不足 |
| 07/12/2023 | -8.02% | 高盛 | $35→$40 | 維護 | 賣 |
| 2023年6月27日 | -33.32% | 摩根士丹利 | $29→$29 | 重申 | 減碼→減碼 |
| 04/27/2023 | -14.92% | Keefe，Bruyette&Wood | $40→$37 | 維護 | 表現不佳 |
| 04/12/2023 | -33.32% | 摩根士丹利 | $30→$29 | 維護 | 體重不足 |
| 03/24/2023 | -17.22% | 高盛 | $40→$36 | 維護 | 賣 |
| 02/09/2023 | -3.43% | 高盛 | $38→$42 | 維護 | 賣 |
| 2023年1月11日 | -14.92% | 高盛 | $40→$37 | 評級下調 | 中性→銷售 |
| 01/09/2023 | -31.02% | 瑞銀集團 | $32→$30 | 維護 | 賣 |
| 11/03/2022 | -8.02% | 摩根大通 | $42→$40 | 維護 | 中性 |
| 11/03/2022 | -14.92% | Keefe，Bruyette&Wood | $40→$37 | 評級下調 | 市場表現→表現不佳 |
| 10/07/2022 | -12.62% | 高盛 | $43→$38 | 維護 | 中性 |
| 09/23/2022 | -19.52% | 瑞銀集團 | $43→$35 | 評級下調 | 中性→銷售 |
| 07/28/2022 | -1.13% | 瑞銀集團 | $40→$43 | 維護 | 中性 |
| 07/18/2022 | -17.22% | 摩根士丹利 | $53→$36 | 評級下調 | 等重→減碼 |
| 07/11/2022 | -3.43% | 沃爾夫研究 | →$42 | 評級下調 | 同行執行→表現不佳 |
| 07/08/2022 | 3.47% | 派珀·桑德勒 | $50→$45 | 維護 | 中性 |
| 07/06/2022 | -8.02% | 瑞銀集團 | $54→$40 | 評級下調 | 購買→中性 |
| 04/28/2022 | 14.97% | 派珀·桑德勒 | →$50 | 評級下調 | 超重→中性 |
| 04/12/2022 | 3.47% | 高盛 | $50→$45 | 維護 | 中性 |
| 04/07/2022 | 19.57% | 派珀·桑德勒 | $61→$52 | 維護 | 超重 |
| 04/06/2022 | 31.06% | Keefe，Bruyette&Wood | →$57 | 評級下調 | 跑贏→市場表現 |
| 03/09/2022 | 40.26% | 派珀·桑德勒 | $70→$61 | 維護 | 超重 |
| 03/08/2022 | 21.87% | 摩根士丹利 | $65→$53 | 維護 | 等重 |
| 02/11/2022 | 60.96% | 派珀·桑德勒 | $78→$70 | 升級 | 中性→超重 |
| 02/10/2022 | 49.46% | 摩根士丹利 | $68→$65 | 維護 | 等重 |
| 01/06/2022 | 49.46% | 高盛 | $68→$65 | 升級 | 賣出→中性 |
| 01/04/2022 | 67.85% | 瑞銀集團 | $85→$73 | 維護 | 買 |
| 2021/12/17 | 77.05% | Keefe，Bruyette&Wood | →$77 | 升級 | 市場表現優於→ |
| 12/08/2021 | 56.36% | 摩根士丹利 | $75→$68 | 維護 | 等重 |
| 10/11/2021 | 56.36% | 摩根士丹利 | $63→$68 | 維護 | 等重 |
| 07/22/2021 | 44.86% | 摩根士丹利 | $60→$63 | 維護 | 等重 |
| 06/17/2021 | 44.86% | 沃爾夫研究 | →$63 | 升級 | 表現不佳的→對等設備 |
| 04/09/2021 | - | JMP證券 | 評級下調 | 市場表現優於→市場表現 | |
| 04/07/2021 | 37.96% | 摩根士丹利 | $57→$60 | 維護 | 等重 |
| 02/11/2021 | 31.06% | 摩根士丹利 | $55→$57 | 維護 | 等重 |
| 2021/11/01 | 26.47% | 摩根士丹利 | $52→$55 | 維護 | 等重 |
| 01/07/2021 | 14.97% | 摩根大通 | $34→$50 | 升級 | 減重→中性 |
| 01/05/2021 | 28.77% | 瑞銀集團 | $40→$56 | 升級 | 中性→購買 |
| 12/16/2020 | - | 環球海港 | 開始承保 | →中性 | |
| 12/14/2020 | 19.57% | 摩根士丹利 | $41→$52 | 維護 | 等重 |
| 10/27/2020 | -5.73% | 派珀·桑德勒 | $37→$41 | 維護 | 中性 |
| 10/12/2020 | -5.73% | 摩根士丹利 | $29→$41 | 維護 | 等重 |
| 10/09/2020 | -3.43% | JMP證券 | $37→$42 | 維護 | 市場表現強於大盤 |
| 10/09/2020 | - | Keefe，Bruyette&Wood | 評級下調 | 跑贏→市場表現 | |
| 08/05/2020 | -44.81% | 高盛 | $27→$24 | 評級下調 | 中性→銷售 |
| 07/30/2020 | -28.72% | 派珀·桑德勒 | $32→$31 | 維護 | 中性 |
| 07/30/2020 | -33.32% | 摩根士丹利 | $31→$29 | 維護 | 等重 |
| 07/13/2020 | -37.92% | 高盛 | $34→$27 | 評級下調 | 購買→中性 |
| 07/10/2020 | -26.42% | 派珀·桑德勒 | $40→$32 | 評級下調 | 超重→中性 |
| 07/07/2020 | -40.22% | 摩根大通 | $20→$26 | 評級下調 | 中性→減持 |
| 04/09/2020 | -28.72% | 摩根士丹利 | $37→$31 | 維護 | 等重 |
| 04/09/2020 | -10.32% | JMP證券 | $45→$39 | 維護 | 市場表現強於大盤 |
| 03/25/2020 | -35.62% | 瑞銀集團 | $33→$28 | 維護 | 中性 |
| 02/06/2020 | 12.67% | 摩根大通 | $44→$49 | 維護 | 超重 |
| 02/06/2020 | -5.73% | 白金漢研究 | $39→$41 | 維護 | 買 |
| 2019年12月11日 | -19.52% | 摩根士丹利 | $37→$35 | 維護 | 等重 |
| 2019年11月20日 | -14.92% | 摩根士丹利 | $39→$37 | 維護 | 等重 |
| 2019年10月09日 | -10.32% | 白金漢研究 | $44→$39 | 維護 | 買 |
| 2019年10月08日 | -10.32% | 摩根士丹利 | $41→$39 | 維護 | 等重 |
| 2019年07月31日 | -10.32% | Keefe，Bruyette&Wood | $42→$39 | 評級下調 | 跑贏→市場表現 |
| 2019年07月11日 | 1.17% | 白金漢研究 | $53→$44 | 維護 | 買 |
| 2019年07月08日 | -5.73% | 摩根士丹利 | $45→$41 | 維護 | 等重 |
| 2019年4月11日 | - | B of A證券 | 評級下調 | 購買表現不佳的→ | |
| 2019年08月04日 | 14.97% | JMP證券 | $56→$50 | 維護 | 市場表現強於大盤 |
| 2019年08月01日 | 5.77% | 摩根士丹利 | $59→$46 | 維護 | 等重 |
| 2018/06/11 | 21.87% | 高盛 | →$53 | 開始承保 | →購買 |
| 2018年10月23日 | 24.17% | 瑞銀集團 | $59→$54 | 維護 | 中性 |
| 10/08/2018 | 35.66% | 瑞銀集團 | $62→$59 | 維護 | 中性 |
What is the target price for Moelis (MC)?
莫裡斯(Moelis)的目標價是多少？
The latest price target for Moelis (NYSE: MC) was reported by UBS on October 3, 2023. The analyst firm set a price target for $30.00 expecting MC to fall to within 12 months (a possible -31.02% downside). 14 analyst firms have reported ratings in the last year.
瑞銀於2023年10月3日報告了Moelis(紐約證券交易所代碼：MC)的最新目標價。這家分析公司將目標價定為30.00美元，預計MC將在12個月內下跌(可能下跌31.02%)。過去一年，有14家分析公司公佈了評級。
What is the most recent analyst rating for Moelis (MC)?
分析師對莫裡斯(Moelis)的最新評級是多少？
The latest analyst rating for Moelis (NYSE: MC) was provided by UBS, and Moelis maintained their sell rating.
對Moelis(紐約證券交易所代碼：MC)的最新分析師評級由瑞銀提供，Moelis維持其賣出評級。
When is the next analyst rating going to be posted or updated for Moelis (MC)?
莫裡斯(Moelis)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Moelis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Moelis was filed on October 3, 2023 so you should expect the next rating to be made available sometime around October 3, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Moelis的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Moelis的上一次評級是在2023年10月3日提交的，所以你應該預計下一次評級將在2024年10月3日左右的某個時候提供。
Is the Analyst Rating Moelis (MC) correct?
分析師評級Moelis(MC)正確嗎？
While ratings are subjective and will change, the latest Moelis (MC) rating was a maintained with a price target of $29.00 to $30.00. The current price Moelis (MC) is trading at is $43.49, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的莫裡斯(MC)評級維持不變，目標價在29.00美元至30.00美元之間。目前Moelis的交易價格為43.49美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。